Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Toichi Takino; “Ono”) announced that the U.S. Food and Drug Administration (FDA) has approved ROMVIMZA™ (vimseltinib), a kinase ...
New data suggests scientific content is being flagged for "nudity." Meanwhile, some influencers' sexually explicit posts pass through, say plastic surgeons.